Oncolytic adenoviruses armed with TNFα and IL-2 enable successful adoptive T-cell therapy of solid tumors

被引：0
|
作者：
Parviainen, S. [1 ]
Havunen, R. [2 ]
Siurala, M. [1 ]
Tahtinen, S. [2 ]
Saha, D. [2 ]
Vaha-Koskela, M. [2 ]
Behr, M. [2 ]
Nettelbeck, D. [3 ]
Ehrhardt, A. [4 ]
Hemminki, A. [1 ]
机构：
[1] TILT Biotherapeut Ltd, Helsinki, Finland
[2] Univ Helsinki, Haartman Inst, Med, Canc Gene Therapy Grp, Helsinki, Finland
[3] German Canc Res Ctr, Oncolyt Adenovirus Grp, Heidelberg, Germany
[4] Univ Witten Herdecke, Fak Gesundheit, Witte, Germany
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2PD
引用
收藏
页码：1 / 1
页数：1
相关论文
共 50 条
  • [1] Enabling successful T-cell therapy of solid tumors with oncolytic adenoviruses armed with TNFα and IL-2
    Hemminki, A.
    Havunen, R.
    Siurala, M.
    Taehtinen, S.
    Saha, D.
    Vaehae-Koskela, M.
    Behr, M.
    Nettelbeck, D.
    Ehrhardt, A.
    Parviainen, S.
    ANNALS OF ONCOLOGY, 2016, 27
  • [2] Adenoviruses Armed with TNFα and IL-2 Successfully Enable Adoptive T-Cell Therapy
    Kalervo, Aino
    Siurala, Mikko
    Havunen, Riikka
    Parviainen, Suvi
    Bramante, Simona
    Saha, Dipongor
    Tahtinen, Siri
    Vaha-Koskela, Markus
    Behr, Michael
    Nettelbeck, Dirk
    Ehrhardt, Anja
    Hemminki, Akseli
    MOLECULAR THERAPY, 2016, 24 : S76 - S76
  • [3] Oncolytic adenoviruses armed with tumor necrosis factor alpha and interleukin-2 enable successful adoptive T cell therapy of solid tumors
    Siurala, Mikko
    Havunen, Riikka
    Santos, Joao
    Tahtinen, Siri
    Saha, Dipongkor
    Vaha-Koskela, Markus
    Behr, Michael
    Nettelbeck, Dirk M.
    Ehrhardt, Anja
    Parviainen, Suvi
    Hemminki, Akseli
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (11)
  • [4] Treating pancreatic cancer with "armed" oncolytic adenoviruses and adoptive T-cell therapy
    Roach, Brett L.
    Yamamoto, Masato
    CANCER RESEARCH, 2024, 84 (06)
  • [5] Oncolytic Adenoviruses Armed with Tumor Necrosis Factor Alpha and Interleukin-2 Enable Successful Adoptive Cell Therapy
    Havunen, Riikka
    Siurala, Mikko
    Sorsa, Suvi
    Groenberg-Vaehae-Koskela, Susanna
    Behr, Michael
    Taehtinen, Siri
    Santos, Joao Manuel
    Karell, Pauliina
    Rusanen, Juuso
    Nettelbeck, Dirk M.
    Ehrhardt, Anja
    Kanerva, Anna
    Hemminki, Akseli
    MOLECULAR THERAPY-ONCOLYTICS, 2017, 4 : 77 - 86
  • [6] Armed oncolytic adenovirus can overcome critical obstacles in adoptive T-cell therapy of solid tumors
    Hemminki, Akseli
    Siurala, Mikko
    Tahtinen, Siri
    Jokimaki, Riikka
    Bramante, Simona
    Parviainen, Suvi
    HUMAN GENE THERAPY, 2014, 25 (11) : A20 - A20
  • [7] IL-2 and TNF-α Coding Adenoviruses Enable Adoptive T Cell Therapy in Metastatic, Solid Cancer by Systemically Activating Tumor-Reactive TILs
    Tahtinen, Siri
    Blattner, Carolin
    Vaha-Koskela, Markus
    Saha, Dipongkor
    Siurala, Mikko
    Havunen, Riikka
    Parviainen, Suvi
    Utikal, Jochen
    Umansky, Viktor
    Hemminki, Akseli
    MOLECULAR THERAPY, 2016, 24 : S160 - S161
  • [8] Combating Solid Tumors with Adoptive T-Cell Therapy
    Genetic Engineering and Biotechnology News, 2022, 42 (07): : 28 - 29
  • [9] Exploring Novel Viro-Immunotherapies Using "Armed" Oncolytic Adenoviruses and Adoptive T-Cell Therapy to Target Pancreatic Ductal Adenocarcinoma
    Roach, Brett L.
    Yamamoto, Masato
    MOLECULAR THERAPY, 2022, 30 (04) : 322 - 322
  • [10] Exploring Novel Viro-Immunotherapies Using "Armed" Oncolytic Adenoviruses and Adoptive T-cell Therapy to Target Pancreatic Ductal Adenocarcinoma
    Roach, Brett L.
    Yamamoto, Masato
    MOLECULAR THERAPY, 2023, 31 (04) : 298 - 299
12345